Using CRISPR/Cas9 to Edit Disease Out of the Genome
Type
Blog Post
Published
June 23, 2022, 1:15 p.m.
...Gerald Schwank, first author of the cystic fibrosis report. “This is a big advantage over induced pluripotent...and many others. “Those off-target effects are important,” she said. “We also really need to get a handle...